Comparison of the antileukemic activity of 5-aza-2′-deoxycytidine, 1-β-d-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia
- 1 January 1984
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 8 (6) , 1043-1049
- https://doi.org/10.1016/0145-2126(84)90059-6
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- 5-AZA-2′-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylationLeukemia Research, 1984
- Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemiaLeukemia Research, 1981
- Toxicology in Mice of the Antileukemic Agent 5-AZA-2'-DeoxycytidineDrug and Chemical Toxicology, 1981
- DNA Methylation and Gene FunctionScience, 1980
- Cellular differentiation, cytidine analogs and DNA methylationPublished by Elsevier ,1980
- Kinetics of phosphorylation of 5-aza-2′-deoxycytidine by deoxycytidine kinaseBiochemical Pharmacology, 1979
- INCORPORATION OF A POTENT ANTILEUKEMIC AGENT, 5-AZA-2'-DEOXYCYTIDINE, INTO DNA OF CELLS FROM LEUKEMIC MICE1977
- Effect of trna from 5-azacytidine-treated hamster fibrosarcoma cells on protein synthesis in vitro in a cell-free systemBiochemical Pharmacology, 1976
- Effect of cytosine arabinoside 5′-triphosphate on mammalian DNA polymeraseBiochemical and Biophysical Research Communications, 1969
- The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y)Biochemical Pharmacology, 1968